Preferential share issue registered and trade with paid subscribed shares ceases
Prostatype Genomics AB ("Prostatype Genomics" or the "Company") has performed a preferential share issue of shares which was finalized on 11 May 2023. The preferential share issue has now been registered with the Swedish Companies Registration Office and the last day for trading with paid subscribed shares (Sw. BTA) is on 12 June 2023. The record date is 14 June 2023, after which paid subscribed shares are transformed to shares as per 16 June 2023.For further information about Prostatype Genomics, please contact: Nicklas Rosendal, Press ContactPhone: +46 708-89 33 34E-mail: nicklas.